July 8, 2013
/PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA), a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders, today announced that it will participate in two upcoming investor conferences.
Tuesday, July 9, 2013
, the executive team will participate in the Piper Jaffray Catalyst Symposium: Emerging Talent in Biopharma in
Wednesday, July 10, 2013
, M.D., Vanda's President and CEO, will deliver a corporate presentation at the JMP Securities Healthcare Conference at
12:00 p.m. Eastern Time
in New York City.
The JMP conference presentation will be available live on Vanda's corporate website, where it will be archived for 30 days. To access this presentation, go to Vanda's website at
and click on the "Presentations" tab on the Investor Relations page. Please connect to the website several minutes prior to the start of the live presentation.
About Vanda Pharmaceuticals Inc
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders.
For more on Vanda Pharmaceuticals Inc., please visit
Senior Vice President & Chief Financial Officer Vanda Pharmaceuticals Inc. (202) 734-3428
SOURCE Vanda Pharmaceuticals Inc.